MedTrace Logo

RORC Genetic Polymorphism of Rheumatoid Arthritis

NCT03615729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2018-08-06

No results posted yet for this study

Summary

Three candidate single nucleotide polymorphisms in the RORC2 gene, rs9826 A/G, rs3790515 C/T and rs3828057 C/T were examined together with estimation of nuclear hormone retinoic acid receptor-related orphan receptor variant 2 serum levels to determine their possible association with susceptibility to and clinical phenotype of rheumatoid arthritis in Egyptian population.

Conditions

  • Genetic Predisposition to Disease

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Khaled M Hassanein, Professor · Assiut University

Eligibility

Min Age
20 Years
Max Age
73 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-03-30
Completion
2018-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03615729 on ClinicalTrials.gov